hg_198211.1

Basic information about the TSS

---

TSS ID: hg_198211.1 Species: human Chr: chrX		Start: 154762900 End: 154762951 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000473552.1 AF067008 JF279874 KC954523 KC954524 KC954525 BC010015 Distance: 0 GeneID: 1736 HGNC/MGI_ID: HGNC:2890 UniProt_ID: U5U768 U5U7S7 U5UA77

Gene_name: dyskerin pseudouridine synthase 1 Gene_symbol: DKC1 Gene_synonyms: Cbf5 NAP57 NOLA4 XAP101 dyskerin Gene_source: HGNC:2890

TATA-Box annotation

---

Distance to TSS:	62
Nearest PromoterID:	NR_110022
Entrez ID:	1736
Nearest Unigene:	Hs.4747
Nearest Refseq:	NM_001363
Nearest Ensembl:	ENSG00000130826
Gene Name:	dyskerin pseudouridine synthase 1
Gene Alias:	CBF5|DKC|DKCX|NAP57|NOLA4|XAP101
Gene Description:	dyskerin pseudouridine synthase 1
Gene Type:	protein-coding
CpG%:	0.13
GC%:	0.726368
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DKC1 p2@DKC1 p3@DKC1 p4@DKC1
Sample		p1@DKC1	p2@DKC1	p3@DKC1	p4@DKC1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	109.28	55.13	2.73	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	115.32	57.05	3.44	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	123.46	70.99	2.31	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	120.59	54.26	3.33	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	121.03	60.07	4.72	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	106.21	55.82	2.13	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	131.17	70.59	5.66	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	109.24	63.46	5.57	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	100.87	58.13	4.70	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	115.93	33.62	17.97	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	87.31	38.00	12.13	6.87
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	109.77	33.74	13.42	8.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.12	3.87	2.26	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.69	4.81	0.75	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	20.20	5.05	0.66	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.86	6.29	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.51	5.24	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.03	5.48	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	16.53	5.33	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	19.56	6.17	0.75	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.71	5.48	1.07	1.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.30	6.90	1.04	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.80	6.33	1.16	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.90	4.61	2.67	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.90	5.42	1.81	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.57	4.43	0.63	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	16.48	9.34	0.55	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.52	7.78	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	18.09	7.27	1.62	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.26	9.95	1.45	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.96	6.49	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.52	6.64	0.20	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.72	7.81	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.10	11.05	0.99	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.75	4.67	0.93	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.63	7.09	1.15	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	19.21	9.20	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.92	5.44	0.60	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.18	6.21	0.27	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.00	8.40	1.68	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	14.35	7.06	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.81	7.03	1.46	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.29	7.38	0.63	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.96	7.52	1.05	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	22.29	8.43	1.41	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.35	5.12	1.86	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.91	10.32	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	19.37	6.86	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.84	5.27	1.68	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.42	5.05	1.42	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.06	4.92	2.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.24	5.34	0.22	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	83.95	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.26	4.26	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.59	2.32	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	41.11	33.56	4.19	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	27.10	11.94	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	16.53	4.21	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.88	3.85	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	47.15	11.94	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	13.40	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	1.68	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	55.73	16.72	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	32.96	8.49	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.95	3.90	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.13	5.32	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	80.82	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	86.87	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	4.39	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.88	3.97	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	13.14	2.81	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	26.83	8.28	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	9.90	3.71	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.48	4.28	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	11.72	5.39	1.43	0.63
Adipocyte - breast, donor2	11327-117E4	9.30	4.33	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	15.52	3.69	1.15	0.89
Adipocyte - omental, donor2	11474-119C7	13.45	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	13.06	3.01	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	8.93	3.19	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	3.30	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.52	12.19	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	12.16	3.48	1.04	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	21.90	6.65	1.37	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	19.82	6.43	1.54	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	20.63	6.97	1.95	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	21.75	2.94	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	26.78	7.08	0.80	1.37
Adipocyte differentiation, day08, donor2	13023-139D8	26.47	5.49	2.90	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	16.00	1.07	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	3.90	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	16.22	4.57	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	13.81	3.27	0.75	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	1.96	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	10.96	3.65	0.91	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	16.35	5.08	1.10	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	9.32	3.94	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.33	3.24	0.90	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.57	1.03	0.82	1.23
Anulus Pulposus Cell, donor1	11248-116E6	8.47	1.95	0.92	1.95
Anulus Pulposus Cell, donor2	11463-119B5	13.22	1.47	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.62	4.94	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.19	3.47	0.43	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.35	4.78	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	7.59	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	3.96	0.00	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.65	6.82	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.96	6.80	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.28	2.38	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.57	7.16	0.75	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	7.26	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.81	5.77	0.66	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.21	3.02	0.45	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.61	6.97	1.07	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.79	4.16	1.13	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.36	3.47	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	15.61	6.83	0.98	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.09	6.14	1.00	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	7.08	0.00	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.72	5.32	0.51	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.62	4.37	0.00	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.66	2.66	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	4.85	1.21	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.82	3.99	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	5.13	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.32	3.10	0.77	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.48	7.04	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	6.11	1.29	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.99	4.28	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	2.92	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.34	5.12	0.90	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	6.10	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.28	3.57	0.00	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.17	1.27	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	4.32	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.64	4.23	0.64	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.15	3.48	0.58	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	7.56	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.88	5.93	1.19	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	8.45	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.08	4.72	1.29	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	2.41	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	2.19	0.00	5.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.87	4.37	0.92	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.69	3.56	0.76	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	13.01	3.72	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.32	2.75	1.22	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	7.65	1.43	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.64	3.55	1.33	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	9.15	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	4.98	1.11	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.77	4.77	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	11.63	2.54	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	12.28	3.32	0.49	0.74
Astrocyte - cerebellum, donor2	11580-120F5	11.13	2.91	0.68	1.03
Astrocyte - cerebellum, donor3	11661-122F5	4.82	0.84	0.00	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	37.65	6.62	3.14	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	33.65	9.71	2.26	2.91
Astrocyte - cerebral cortex, donor3	11392-118C6	39.53	11.34	2.09	2.54
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	77.87	34.18	3.44	3.56
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	92.96	47.98	3.88	3.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	95.02	36.64	3.64	3.76
Basophils, donor1	12241-129G9	6.80	2.09	2.62	4.18
Basophils, donor2	12242-129H1	20.57	4.69	8.30	11.18
Basophils, donor3	12243-129H2	10.58	3.53	3.38	5.59
Bronchial Epithelial Cell, donor1	11511-119G8	8.19	2.59	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	0.46	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	11.30	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	25.37	12.68	0.62	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	26.48	13.59	1.15	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	27.89	7.38	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	84.61	56.17	2.27	2.58
Burkitt's lymphoma cell line:RAJI	10476-106I8	103.88	74.06	3.49	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	57.56	33.90	11.19	16.63
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	14.09	2.82	5.64	9.02
CD14+ Monocytes, donor2	11305-117B9	18.75	2.41	2.60	3.53
CD14+ Monocytes, donor3	11381-118B4	15.15	2.85	2.41	4.17
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.00	6.51	2.26	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.20	4.93	3.03	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	16.77	3.29	0.99	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	11.27	5.78	1.73	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	15.09	6.34	2.41	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	16.82	5.45	1.42	2.37
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.53	2.34	1.17	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.90	4.42	0.83	2.48
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	21.82	9.67	1.49	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.62	3.52	1.37	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	15.67	4.45	1.60	1.78
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.54	3.70	2.83	2.18
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.35	3.04	1.17	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	21.65	9.50	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	8.87	3.33	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.45	5.50	1.04	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.57	7.38	1.40	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	15.61	9.99	1.87	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.07	5.03	1.14	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.89	4.30	0.90	2.04
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	14.84	4.80	0.44	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	10.76	4.84	0.81	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.10	6.46	1.57	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	17.67	5.05	3.37	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	12.31	4.04	0.73	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	15.50	3.52	2.11	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.99	3.07	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.59	3.14	1.39	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.73	4.46	1.86	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	19.18	3.45	2.16	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.47	6.55	2.05	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.52	3.48	1.62	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	15.54	4.87	1.86	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	13.51	8.72	1.74	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	14.55	4.39	1.85	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	16.03	8.23	1.30	3.03
CD14+CD16- Monocytes, donor1	11788-124B6	14.33	7.94	1.40	2.34
CD14+CD16- Monocytes, donor2	11799-124C8	15.02	6.64	2.10	2.27
CD14+CD16- Monocytes, donor3	11910-125G2	24.53	8.03	3.34	3.12
CD14-CD16+ Monocytes, donor1	11790-124B8	11.23	2.81	2.30	2.81
CD14-CD16+ Monocytes, donor2	11800-124C9	12.95	5.71	1.54	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	18.32	5.47	1.68	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	6.10	6.10	14.23
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	40.00	5.42	4.07	6.78
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	2.07	6.21	8.28
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	36.78	8.53	6.40	9.06
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	41.28	7.50	8.58	17.15
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.89	3.51	4.91	10.53
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	6.27	7.84	9.41
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	30.32	3.95	7.91	11.86
CD19+ B Cells, donor1	11544-120B5	32.88	3.29	9.86	18.08
CD19+ B Cells, donor2	11624-122B4	21.04	2.90	10.88	18.14
CD19+ B Cells, donor3	11705-123B4	22.72	2.52	12.62	16.66
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	83.64	90.10	2.42	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	72.71	67.51	2.00	2.00
CD34+ Progenitors, donor1	11545-120B6	20.08	5.02	6.02	6.02
CD34+ Progenitors, donor2	11625-122B5	19.66	1.12	8.99	16.29
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	58.24	60.12	6.39	4.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	59.30	57.95	6.31	8.79
CD4+ T Cells, donor1	11225-116C1	27.14	1.79	7.14	26.78
CD4+ T Cells, donor2	11306-117C1	17.76	1.84	9.19	23.27
CD4+ T Cells, donor3	11382-118B5	17.38	1.22	5.79	12.81
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	28.84	13.27	2.81	5.10
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	32.12	8.76	1.80	4.94
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	29.61	6.32	3.74	4.60
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	30.82	1.42	10.90	12.33
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	36.52	1.40	12.64	14.05
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	3.30	3.30	9.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	21.10	6.94	2.89	2.60
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	18.81	6.78	2.03	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.83	5.96	1.29	3.22
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.07	3.14	6.72	7.17
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.26	3.14	5.24	6.29
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	26.40	1.32	3.52	8.80
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	31.62	10.96	4.64	5.06
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	21.82	4.57	2.08	3.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	21.38	5.35	1.67	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	34.54	2.18	7.89	18.22
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	36.98	2.68	9.11	18.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	50.21	1.79	12.55	19.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.71	13.54	2.41	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.78	10.18	0.65	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	23.75	8.41	1.68	2.94
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	25.79	2.02	9.61	6.57
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	23.83	3.47	9.96	9.96
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	30.07	2.18	8.72	10.46
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	42.06	3.96	8.41	14.35
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	31.39	4.62	6.46	16.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	37.69	2.79	15.35	12.56
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	47.63	6.65	14.40	16.89
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	59.63	5.64	13.99	18.16
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	43.12	1.54	9.24	13.86
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	41.90	2.86	10.03	9.67
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	48.47	1.38	15.23	11.08
CD8+ T Cells, donor1	11226-116C2	22.92	3.27	7.53	14.73
CD8+ T Cells, donor2	11307-117C2	18.02	0.75	9.01	15.77
CD8+ T Cells, donor3	11383-118B6	29.54	1.77	10.35	18.68
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	66.06	38.31	2.06	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	59.91	32.59	2.40	2.88
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	55.54	33.65	3.56	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	57.04	31.82	3.30	4.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	53.04	30.72	2.64	3.12
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	57.76	33.88	3.18	3.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	53.45	34.77	1.74	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	47.90	30.79	2.11	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	50.42	32.83	1.41	1.88
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	52.22	32.00	1.51	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	45.03	29.34	1.45	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	63.41	33.57	1.60	2.93
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	38.08	11.82	2.19	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	42.35	10.02	2.28	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	30.58	9.70	5.22	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	61.59	26.29	5.04	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	68.19	29.64	3.74	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	57.04	21.68	2.36	4.01
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	67.82	43.42	1.58	2.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	60.90	45.21	1.85	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	58.35	34.30	2.89	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	50.10	31.74	2.29	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	50.05	23.65	1.97	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	40.85	20.42	4.54	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	26.50	10.44	2.41	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	29.38	6.99	2.80	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	7.01	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	38.38	9.14	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	23.72	5.93	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	20.10	7.79	0.53	1.79
Chondrocyte - de diff, donor1	11261-116G1	28.43	11.09	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	10.66	2.84	1.42	1.78
Chondrocyte - de diff, donor3	11410-118E6	14.34	5.12	0.68	0.91
Chondrocyte - re diff, donor2	11339-117F7	51.92	19.70	6.27	3.58
Chondrocyte - re diff, donor3	11411-118E7	14.96	5.26	1.21	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	28.00	8.61	1.84	2.87
Ciliary Epithelial Cells, donor2	11323-117D9	18.17	8.12	1.28	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	21.06	8.67	1.59	1.77
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.83	7.15	2.84	2.93
Corneal Epithelial Cells, donor1	11526-119I5	5.49	2.63	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	7.96	2.28	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	9.20	5.37	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	11.89	4.79	1.65	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.04	2.84	0.00	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	12.31	6.16	0.32	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	24.94	7.52	6.15	16.06
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.07	5.22	7.18	13.06
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.97	5.32	10.16	20.33
Endothelial Cells - Aortic, donor0	11207-116A1	25.02	10.67	0.67	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	26.99	4.11	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	25.45	10.18	1.41	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	22.80	6.68	1.57	1.57
Endothelial Cells - Artery, donor1	11264-116G4	17.74	4.94	0.29	1.75
Endothelial Cells - Artery, donor2	11341-117F9	21.41	16.23	0.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	35.24	17.18	0.35	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.96	3.55	1.55	1.77
Endothelial Cells - Lymphatic, donor2	11317-117D3	18.86	5.48	1.52	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	22.83	7.33	1.69	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	14.86	3.57	0.89	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	15.62	9.37	0.52	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	8.37	1.84	0.85	1.42
Endothelial Cells - Thoracic, donor1	11266-116G6	52.02	37.21	2.00	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	15.72	5.77	0.00	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	47.34	22.49	1.86	2.11
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.28	7.17	1.74	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	48.00	13.43	1.95	2.81
Endothelial Cells - Vein, donor1	11267-116G7	20.48	9.10	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	10.48	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	27.16	11.15	0.63	1.41
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	26.40	1.65	1.65	4.95
Eosinophils, donor3	12246-129H5	10.70	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.38	1.47	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.99	5.34	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.34	2.74	0.22	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.47	5.31	1.08	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.74	14.07	1.21	1.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	24.97	14.88	0.14	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	17.19	5.48	1.58	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.97	8.70	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	21.26	12.96	1.99	1.00
Fibroblast - Cardiac, donor1	11268-116G8	26.31	11.79	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	15.92	4.55	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.36	4.10	1.10	0.95
Fibroblast - Cardiac, donor4	11452-119A3	23.64	9.40	1.82	0.61
Fibroblast - Cardiac, donor5	11456-119A7	33.76	13.58	1.52	1.27
Fibroblast - Cardiac, donor6	11460-119B2	29.56	13.34	0.91	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.99	3.35	0.67	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	14.24	3.45	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	8.79	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	27.22	9.23	2.54	2.54
Fibroblast - Conjunctival, donor3	11692-122I9	15.26	3.90	1.36	1.36
Fibroblast - Dermal, donor1	11269-116G9	21.37	8.92	0.70	0.94
Fibroblast - Dermal, donor2	11346-117G5	27.83	12.74	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	22.48	9.55	1.21	0.97
Fibroblast - Dermal, donor4	11450-119A1	55.05	18.77	1.58	1.36
Fibroblast - Dermal, donor5	11454-119A5	67.51	26.52	1.57	1.92
Fibroblast - Dermal, donor6	11458-119A9	67.73	29.40	1.62	1.95
Fibroblast - Gingival, donor1	11237-116D4	26.03	11.24	1.87	2.50
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	24.89	6.55	1.57	1.05
Fibroblast - Gingival, donor2	11318-117D4	29.26	12.12	1.58	1.71
Fibroblast - Gingival, donor3	11394-118C8	24.85	4.45	2.13	2.22
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	17.66	4.16	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.33	2.29	0.70	1.94
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.45	9.82	2.49	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.48	9.47	1.22	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	2.47	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	28.23	6.43	1.46	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.13	8.04	1.36	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	55.94	25.23	2.08	1.43
Fibroblast - Gingival, donor9 (control)	11927-125I1	16.14	1.91	1.76	1.32
Fibroblast - Lung, donor1	11270-116H1	13.59	2.72	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	8.95	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	22.37	9.50	1.06	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	12.50	7.50	1.67	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	0.56	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	22.73	8.53	1.22	2.03
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	39.18	14.74	1.75	2.52
Fibroblast - Periodontal Ligament, donor2	11319-117D5	50.51	13.35	1.97	2.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	39.78	17.75	1.53	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.82	7.63	1.53	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.98	6.48	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	15.89	3.13	1.04	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.41	21.33	1.66	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	16.05	4.67	1.22	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	12.03	4.68	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	5.14	1.19	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	26.00	9.72	0.99	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	13.85	4.62	1.24	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	18.92	7.29	1.38	2.56
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	24.37	9.63	0.90	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	26.99	10.58	1.51	1.84
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.54	7.09	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	20.02	5.09	0.82	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	26.47	12.63	1.40	0.60
Fibroblast - skin normal, donor2	11561-120D4	26.12	8.44	1.51	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.41	11.79	1.81	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.30	5.63	1.41	1.82
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	25.13	6.84	1.20	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.09	5.91	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.22	10.55	1.49	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	27.49	12.99	1.69	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.19	5.02	0.78	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	265.92	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.91	16.56	2.61	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.70	9.19	0.52	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.26	15.35	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.15	17.12	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	73.49	29.86	6.12	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	61.89	29.99	7.66	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	170.30	37.37	11.41	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	60.12	7.72	6.62	11.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	53.43	4.57	6.62	5.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	104.81	20.61	6.74	5.15
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	52.60	4.23	7.14	5.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	47.94	3.26	8.48	6.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	128.69	30.51	8.84	5.75
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	62.32	25.16	6.78	4.80
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	47.78	11.58	6.28	2.59
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	50.23	22.03	3.22	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	42.74	12.88	4.34	2.85
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	52.88	15.09	4.15	3.32
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	50.01	17.89	1.22	2.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	27.84	7.99	2.74	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.51	9.09	1.99	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.07	4.81	3.93	2.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.91	6.50	2.95	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	38.63	10.33	2.86	2.54
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	34.41	7.37	2.23	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	30.45	8.87	2.22	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.71	11.37	2.54	3.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.22	16.94	1.95	2.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.59	6.04	2.91	1.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.91	7.34	2.39	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	39.17	9.85	2.88	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.78	14.06	1.83	1.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.37	10.82	1.63	3.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.76	3.71	2.27	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.59	7.61	2.65	2.77
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.85	9.67	2.17	1.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	20.72	4.41	2.42	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	37.39	5.29	2.83	2.21
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.53	7.46	2.11	1.78
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.90	5.13	2.57	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.00	5.69	1.04	1.52
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.68	7.12	1.42	1.90
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.89	6.08	1.52	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	23.21	7.63	1.05	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	21.52	4.83	1.10	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.92	4.49	1.96	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.00	7.13	2.04	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.66	8.56	1.07	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.02	10.71	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	24.09	9.97	1.42	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.87	7.05	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	18.44	3.69	2.21	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.49	2.63	1.32	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	18.84	0.99	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.92	3.83	0.92	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.33	3.43	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	18.81	2.29	1.78	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	102.91	46.18	9.16	8.56
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	81.04	22.65	6.78	5.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	105.56	39.08	12.89	11.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.57	23.16	3.76	5.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	43.23	23.17	2.83	3.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	70.56	36.90	6.46	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	17.32	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	56.86	30.17	3.87	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	20.86	4.81	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	20.87	5.22	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	49.15	22.78	1.95	2.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	64.24	22.65	3.29	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	13.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	47.26	20.13	2.24	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	45.76	21.57	1.96	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.14	13.42	2.52	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	44.21	15.27	2.54	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	45.51	18.00	2.38	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	20.88	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	53.83	18.33	4.58	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	37.89	9.47	1.48	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	8.47	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	45.56	18.23	1.24	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	43.72	14.27	2.99	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	10.54	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	30.75	9.99	3.46	3.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	27.06	12.39	1.96	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.08	4.01	1.34	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	32.36	6.16	3.08	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	68.13	31.84	5.14	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	38.22	4.25	3.30	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	43.45	4.83	1.81	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	44.76	6.61	3.05	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	47.46	11.97	1.99	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	44.90	3.45	4.44	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	36.59	7.08	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	36.76	8.17	3.50	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.57	2.63	1.76	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	32.21	6.78	2.54	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	25.07	9.55	2.39	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	10.19	1.46	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	5.71	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.40	4.99	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	5.62	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.78	2.22	1.59	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.61	1.67	1.67	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	66.03	61.27	1.28	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	63.47	61.61	2.19	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	66.66	69.84	1.14	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	62.63	56.73	0.66	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.29	64.26	1.07	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	73.41	66.52	1.08	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	49.82	51.93	1.12	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	49.92	50.61	1.20	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	48.70	44.53	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.83	5.04	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.92	1.73	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	7.93	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.47	1.41	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.10	14.69	1.40	1.57
Hepatocyte, donor1	11523-119I2	15.74	4.84	0.00	1.21
Hepatocyte, donor2	11603-120I1	42.02	18.31	0.00	0.00
Hepatocyte, donor3	11684-122I1	26.38	9.20	1.84	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	65.92	37.86	2.61	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	41.77	26.04	2.27	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.72	11.80	0.96	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	85.97	57.31	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	26.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	81.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	69.22	31.84	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	45.05	25.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	23.74	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	76.89	51.26	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	18.28	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	79.59	29.24	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	58.36	30.01	3.33	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	39.94	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	63.53	50.29	5.29	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	54.32	19.96	2.22	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	26.19	10.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	67.40	43.46	1.89	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	88.16	38.67	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	77.52	54.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	83.72	57.96	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	65.19	59.49	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	53.74	40.30	0.84	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	80.37	49.83	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	58.17	52.63	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	56.64	37.29	1.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	60.77	38.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	68.87	52.73	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	100.37	63.52	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	93.10	69.51	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	91.13	54.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	47.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	80.69	79.26	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	132.73	76.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	62.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	69.76	57.10	1.54	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	119.41	79.02	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	116.30	69.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	92.49	62.58	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	8.85	6.64	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	42.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	37.49	19.18	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	42.75	13.50	6.75	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	62.72	20.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	42.67	17.07	3.20	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	66.50	45.72	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	91.19	48.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	43.26	23.93	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	9.08	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	6.21	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	47.58	15.86	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	22.93	15.59	0.33	0.73
Keratinocyte - epidermal, donor2	11349-117G8	21.67	10.54	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	36.92	18.46	0.76	0.95
Keratinocyte - oral, donor1	11251-116E9	46.20	18.28	1.59	1.02
Keratocytes, donor1	11527-119I6	33.70	8.25	0.69	2.06
Keratocytes, donor2	11607-120I5	14.06	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	42.68	7.51	2.37	4.15
Krukenberg tumor cell line:HSKTC	10687-109F3	134.07	6.59	26.37	13.19
Lens Epithelial Cells, donor1	11529-119I8	31.28	8.63	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	17.30	3.00	1.73	1.04
Lens Epithelial Cells, donor3	11690-122I7	18.87	6.26	1.51	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.24	9.49	1.42	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.72	6.70	1.12	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.09	9.13	0.94	2.68
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	5.91	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.18	5.67	0.63	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	17.25	8.09	1.08	1.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.59	9.44	0.41	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.35	3.79	1.26	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.05	6.47	0.70	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.17	5.93	0.79	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.29	10.08	0.97	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.74	3.70	1.30	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.72	5.57	1.39	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.55	5.25	1.91	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.54	4.94	0.69	1.37
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	23.71	4.62	1.54	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	5.30	0.62	1.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	16.47	7.69	0.73	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.82	7.24	1.65	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.64	4.69	0.88	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	16.18	5.97	0.50	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.28	8.24	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.27	3.77	1.35	2.15
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	18.62	8.02	1.36	1.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.18	4.67	2.07	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.87	6.07	0.84	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.50	7.52	1.35	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	6.88	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.93	7.15	0.19	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	13.89	6.04	1.17	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	16.96	7.75	1.94	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	9.26	6.62	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.25	4.71	1.12	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	17.77	7.77	0.74	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.11	8.65	1.48	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	13.89	6.46	0.69	1.51
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.76	7.40	0.96	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.09	9.13	0.61	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.08	9.24	1.40	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	21.33	9.24	1.07	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.09	11.63	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.74	5.14	0.47	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.19	6.09	1.43	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.33	8.17	1.31	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.12	4.00	0.24	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.00	13.61	2.10	1.73
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.09	3.07	0.26	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.27	6.56	0.90	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	2.27	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	7.67	0.00	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	4.45	0.74	5.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	26.23	8.89	3.39	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.99	7.03	2.11	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	7.47	1.87	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	26.28	9.79	2.06	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	3.57	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.64	11.08	2.04	2.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.32	16.29	3.20	4.65
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.21	15.76	3.15	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.34	10.43	2.98	2.44
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	24.14	8.22	3.59	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.40	10.59	2.82	4.23
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	26.65	9.99	1.33	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	29.03	15.28	1.02	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	37.62	14.94	4.80	4.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	42.51	14.93	2.46	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	31.91	12.27	2.45	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	35.06	10.60	3.26	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	39.57	13.33	2.92	3.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	40.64	17.38	2.24	3.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	9.27	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	41.51	23.22	3.19	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.07	18.53	2.09	3.89
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	44.26	16.60	3.32	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.52	16.61	1.41	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.82	16.23	1.84	4.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	31.08	14.97	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	28.01	11.51	1.54	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.27	9.62	4.53	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	6.56	2.46	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	29.37	10.39	1.81	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.03	15.08	1.44	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	28.38	14.94	2.99	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	38.27	15.61	1.11	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	36.61	14.21	3.02	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.97	18.84	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	30.32	17.33	1.67	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	10.86	1.21	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.04	7.11	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	22.34	9.62	1.72	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	27.37	9.12	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	24.24	4.04	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.37	12.22	1.85	3.70
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	8.14	4.65	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	1.06	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.81	10.00	1.20	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	26.89	11.63	1.45	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	30.66	9.96	3.83	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.64	7.89	0.99	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	10.35	2.82	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.65	9.05	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	26.59	6.31	3.60	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	12.05	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	23.16	13.36	0.89	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	38.71	9.78	1.96	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	13.19	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	8.82	3.63	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	32.38	15.75	1.75	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	25.16	20.69	2.24	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.96	14.13	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	35.87	18.13	2.70	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	42.53	11.14	2.53	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	32.68	13.94	3.36	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.05	14.31	1.99	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	33.42	16.41	0.61	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	33.20	11.76	0.69	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	36.86	15.20	2.28	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	34.60	19.62	1.55	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	24.79	12.09	1.81	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	35.18	20.92	3.80	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	45.31	20.79	1.60	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.84	18.96	1.15	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	42.17	21.08	1.03	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	34.66	12.73	4.24	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	30.64	21.00	1.70	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.45	17.47	0.42	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	38.37	18.79	2.35	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.90	16.70	1.25	3.34
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	28.81	16.73	0.93	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.12	14.05	0.67	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	40.10	27.27	4.28	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	44.85	25.86	4.04	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.04	17.44	1.84	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	26.67	22.23	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	37.61	17.67	0.57	3.42
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.07	19.17	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	29.00	17.51	2.19	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	38.75	17.37	1.78	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.30	17.16	3.64	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	25.86	21.88	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	35.34	8.31	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.85	5.47	0.68	0.68
Macrophage - monocyte derived, donor2	11313-117C8	13.03	6.24	0.55	1.10
Macrophage - monocyte derived, donor3	11389-118C3	16.65	6.16	0.39	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.99	15.40	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	20.44	10.30	1.11	0.16
Mallassez-derived cells, donor3	11930-125I4	30.16	24.74	0.28	0.69
Mammary Epithelial Cell, donor1	11273-116H4	69.75	48.53	2.49	1.49
Mammary Epithelial Cell, donor2	11350-117G9	47.20	31.85	0.58	0.58
Mammary Epithelial Cell, donor3	11422-118F9	21.45	9.48	0.50	0.75
Mast cell - stimulated, donor1	11487-119E2	70.51	50.85	15.59	6.78
Mast cell, donor1	11563-120D6	35.04	8.33	4.33	5.84
Mast cell, donor2	11565-120D8	50.52	2.67	11.00	16.64
Mast cell, donor3	11566-120D9	51.55	4.28	10.58	20.94
Mast cell, donor4	11567-120E1	48.58	1.95	9.22	14.36
Mast cell, expanded and stimulated, donor5	11940-126A5	43.25	13.31	3.99	6.65
Mast cell, expanded and stimulated, donor8	11942-126A7	32.10	21.60	4.67	4.09
Mast cell, expanded, donor5	11939-126A4	29.37	7.69	3.67	3.67
Mast cell, expanded, donor8	11941-126A6	27.45	5.36	2.01	3.51
Melanocyte - dark, donor1	11502-119F8	31.24	11.74	1.79	2.09
Melanocyte - dark, donor2	11582-120F7	14.88	6.23	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	27.38	13.84	1.52	0.65
Melanocyte - light, donor1	11274-116H5	8.23	4.00	0.47	0.24
Melanocyte - light, donor2	11351-117H1	8.87	2.73	0.68	0.00
Melanocyte - light, donor3	11423-118G1	10.41	3.47	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	32.49	21.35	0.94	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	20.44	12.10	1.08	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	23.57	10.98	0.27	0.54
Meningeal Cells, donor1	11493-119E8	27.29	7.82	0.74	1.74
Meningeal Cells, donor2	11573-120E7	29.93	10.56	2.64	1.32
Meningeal Cells, donor3	11654-122E7	37.16	24.69	1.63	1.79
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	28.52	9.70	1.14	1.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.32	8.45	0.60	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	3.92	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	12.92	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.19	4.24	0.64	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	4.52	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.77	4.18	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	14.61	5.84	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.91	2.86	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	14.27	3.05	0.55	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.69	2.60	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.21	6.58	0.39	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.93	1.78	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	3.84	1.28	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	43.95	34.03	1.06	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.01	5.00	0.63	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	16.69	2.18	1.45
Mesothelial Cells, donor1	11247-116E5	16.97	5.30	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	11.51	2.00	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	10.55	3.76	0.72	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.19	6.90	0.99	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	13.25	3.83	0.59	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.57	4.34	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.37	7.05	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00	2.32	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	14.52	2.75	0.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.64	5.59	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.97	3.25	0.41	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.09	2.77	0.00	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	3.54	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.26	5.32	0.00	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	1.32	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.19	2.55	0.42	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	1.84	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.94	2.98	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	1.68	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.03	5.77	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.51	5.23	0.48	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.19	2.21	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.75	3.45	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.83	4.21	0.63	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.15	3.87	1.02	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.87	3.86	0.86	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.67	3.11	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	2.03	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.97	3.26	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.94	4.12	0.59	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	1.09	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.32	1.44	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.81	2.80	0.80	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.51	2.50	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	6.12	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.70	3.94	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	11.53	3.84	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.41	5.21	0.50	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.31	5.13	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.75	3.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.20	3.20	1.07	2.49
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.22	2.81	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.55	4.99	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	1.75	1.17	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.54	4.22	0.60	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.95	9.18	0.83	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	15.70	2.77	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.11	7.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.27	2.76	1.11	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.22	5.44	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.30	5.15	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.99	1.27	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.28	2.67	0.27	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.57	4.49	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.16	2.54	1.41	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	5.10	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.06	4.42	0.88	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	2.65	0.38	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.80	3.13	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.36	3.44	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	8.53	2.65	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.50	3.75	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.66	2.06	1.24	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.64	1.79	0.60	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	17.41	5.91	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	6.31	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.27	4.15	1.19	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.01	0.93	0.93	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	18.03	7.89	1.50	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.59	4.53	1.33	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.70	7.01	0.79	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	2.21	1.47	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.49	5.13	1.83	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	9.33	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.57	6.41	0.53	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	7.07	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	3.79	2.11	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	5.45	0.00	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	1.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	1.62	1.62	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	4.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	16.31	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.19	10.99	1.08	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.90	4.70	2.09	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.94	2.09	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	76.25	20.73	0.95	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	121.28	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	80.86	36.75	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.02	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.27	4.65	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.49	1.62	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.29	2.10	1.26	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	144.75	33.40	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.96	1.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.78	4.33	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.39	1.13	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.96	1.80	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.59	2.55	1.09	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	1.06	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	37.74	8.20	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.37	0.81	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.05	4.76	1.23	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.03	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.96	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	42.77	8.28	1.38	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	134.01	22.76	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	17.60	1.56	1.11	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	2.96	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.84	1.66	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.73	1.29	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	36.11	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.66	1.67	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.49	1.80	1.80	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.32	2.38	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.84	2.65	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.82	1.96	0.98	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	0.44	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	1.36	2.26	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	1.33	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	3.97	2.48	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.98	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	17.54	1.51	0.00	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.74	4.86	1.55	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	66.42	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	10.07	0.94	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.08	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.96	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	10.20	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	20.13	12.92	0.37	0.25
Myoblast, donor2	11322-117D8	26.66	10.55	0.77	0.58
Myoblast, donor3	11398-118D3	29.93	9.08	1.01	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	120.69	52.24	8.17	3.21
Natural Killer Cells, donor1	11230-116C6	27.06	1.85	6.15	15.99
Natural Killer Cells, donor2	11311-117C6	18.39	2.71	6.63	10.25
Natural Killer Cells, donor3	11387-118C1	18.04	1.29	7.18	12.33
Neural stem cells, donor1	11275-116H6	41.74	15.97	2.54	6.53
Neural stem cells, donor2	11352-117H2	53.92	9.63	5.78	5.78
Neurons, donor1	11494-119E9	33.00	11.38	4.55	5.69
Neurons, donor2	11574-120E8	29.28	6.83	3.30	1.98
Neurons, donor3	11655-122E8	50.97	6.58	3.29	4.93
Neutrophils, donor1	11233-116C9	12.06	1.86	1.86	0.00
Neutrophils, donor2	11314-117C9	5.80	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	6.72	1.22	1.83	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	14.84	3.32	1.07	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	7.49	1.30	0.98	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	22.26	2.81	1.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	15.97	4.82	0.83	1.24
Olfactory epithelial cells, donor2	11934-125I8	26.63	5.21	1.16	0.87
Olfactory epithelial cells, donor3	11935-125I9	18.84	4.77	0.79	0.23
Olfactory epithelial cells, donor4	11936-126A1	24.06	4.68	0.97	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	31.90	7.82	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	11.70	2.98	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	7.45	1.86	1.24	0.00
Osteoblast, donor1	11277-116H8	21.69	7.43	1.95	2.15
Osteoblast, donor2	11354-117H4	33.01	28.09	3.51	4.92
Osteoblast, donor3	11426-118G4	24.70	7.11	0.89	2.13
Pancreatic stromal cells, donor1	11249-116E7	19.88	8.42	1.10	1.18
Pericytes, donor1	11491-119E6	2.56	0.22	0.22	0.00
Pericytes, donor2	11571-120E5	3.17	1.36	0.45	0.23
Pericytes, donor3	11652-122E5	9.16	2.24	0.61	1.02
Perineurial Cells, donor1	11499-119F5	24.41	10.06	0.90	1.02
Perineurial Cells, donor2	11579-120F4	21.35	9.20	0.55	1.20
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	26.77	5.42	9.24	11.79
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.16	3.43	4.90	5.63
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	20.71	3.24	4.53	10.35
Placental Epithelial Cells, donor1	11278-116H9	14.83	5.50	1.67	0.96
Placental Epithelial Cells, donor2	11355-117H5	12.20	5.54	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	13.74	3.73	0.59	2.36
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.28	2.22	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	12.38	4.50	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.62	3.79	0.26	0.26
Preadipocyte - breast, donor2	11328-117E5	13.06	3.83	0.68	1.35
Preadipocyte - omental, donor1	11468-119C1	12.15	5.11	0.53	0.75
Preadipocyte - omental, donor2	11329-117E6	15.28	4.36	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	18.05	6.73	1.15	0.86
Preadipocyte - perirenal, donor1	11469-119C2	17.72	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	12.28	9.21	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	40.37	26.56	1.95	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	26.56	11.24	0.85	1.53
Preadipocyte - visceral, donor1	11280-116I2	43.31	22.73	1.40	1.49
Preadipocyte - visceral, donor2	11357-117H7	26.69	10.58	0.00	2.30
Preadipocyte - visceral, donor3	11429-118G7	30.30	15.36	0.73	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	45.26	38.62	1.96	2.26
Prostate Epithelial Cells, donor2	11331-117E8	9.48	4.60	0.14	0.68
Prostate Epithelial Cells, donor3	11404-118D9	29.76	9.06	1.65	0.98
Prostate Stromal Cells, donor1	11254-116F3	29.73	20.62	1.03	0.46
Prostate Stromal Cells, donor2	11332-117E9	32.09	17.93	1.08	1.43
Prostate Stromal Cells, donor3	11405-118E1	11.89	3.23	0.94	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.50	2.19	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.95	4.71	0.69	0.83
Renal Epithelial Cells, donor1	11517-119H5	10.65	1.01	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	12.80	2.13	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	21.07	6.25	1.27	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.31	5.26	0.67	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	45.51	16.43	1.55	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	0.67	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	8.36	2.42	0.66	0.44
Renal Mesangial Cells, donor2	11598-120H5	12.54	4.39	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	1.94	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.33	6.98	0.54	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	1.27	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.87	2.89	0.39	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	37.86	9.59	1.04	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.50	3.13	1.99	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	3.09	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.35	9.03	2.26	2.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	22.45	5.08	1.34	2.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	73.26	15.19	0.89	5.36
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	53.94	44.58	2.20	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	98.03	29.58	8.12	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	99.47	58.90	4.68	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	68.32	35.85	2.09	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	75.40	59.34	2.57	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	101.96	74.30	2.85	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	68.41	39.63	2.80	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	79.28	48.77	3.70	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	64.21	38.75	2.88	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	68.68	37.21	2.87	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	65.40	31.90	2.69	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	64.84	39.59	2.58	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	62.99	32.62	3.00	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	70.81	42.93	1.55	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	72.26	43.01	2.49	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	73.69	37.82	2.61	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	74.97	63.51	3.38	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	88.38	42.86	3.58	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	78.46	41.47	3.50	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	75.81	50.60	1.91	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	71.77	49.23	3.10	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	66.99	35.88	4.48	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	84.42	44.60	4.44	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	86.24	43.94	2.92	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	61.56	34.83	2.70	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	74.28	54.67	2.82	4.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	69.82	54.25	3.77	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	65.28	44.44	3.57	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	86.52	51.21	3.04	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	66.15	50.39	3.11	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	82.29	49.77	3.54	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	87.31	48.46	1.67	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	78.33	51.55	2.29	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	94.85	48.19	6.30	4.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	90.42	63.62	3.28	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	64.48	44.53	3.78	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	75.58	33.88	4.66	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	67.15	45.64	3.12	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	59.48	28.97	1.70	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	67.32	46.46	2.22	2.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	58.37	28.25	2.13	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	62.63	34.57	1.38	4.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	55.48	33.10	1.67	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	71.95	26.00	2.22	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	46.15	27.40	2.35	2.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	63.58	30.74	3.49	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	61.05	23.87	5.74	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	45.04	24.35	1.96	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	77.43	44.54	5.39	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	54.15	23.73	4.87	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.65	19.29	2.41	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	53.38	24.88	1.81	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	51.52	18.57	2.40	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	57.38	35.30	2.24	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	51.23	20.70	2.77	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	70.92	14.42	1.20	1.20
Schwann Cells, donor1	11498-119F4	10.53	1.88	0.94	1.13
Schwann Cells, donor2	11578-120F3	47.63	10.21	0.00	3.40
Schwann Cells, donor3	11659-122F3	15.12	5.26	1.53	0.88
Sebocyte, donor1	11220-116B5	42.73	32.87	1.64	0.00
Sebocyte, donor2	11301-117B5	24.82	17.00	2.30	1.84
Sebocyte, donor3	11378-118B1	13.40	6.18	0.41	0.21
Sertoli Cells, donor1	11255-116F4	19.88	8.28	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	31.41	14.96	2.73	2.11
Skeletal Muscle Cells, donor2	11358-117H8	2.89	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.10	9.20	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	43.20	22.31	1.41	1.41
Skeletal Muscle Cells, donor5	11455-119A6	43.70	16.05	1.19	1.34
Skeletal Muscle Cells, donor6	11459-119B1	55.56	24.01	2.00	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	23.82	9.07	2.77	2.27
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.26	7.28	1.57	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.20	18.06	1.98	2.58
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	28.14	13.31	2.27	1.43
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	24.61	11.58	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.25	2.75	1.10	0.83
Skin - palm, donor1	10286-104F7	99.39	8.06	16.12	16.12
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.86	4.32	0.86	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	49.89	18.81	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.71	7.53	0.78	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	23.49	15.71	1.67	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	33.90	13.08	2.11	2.53
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	60.05	30.45	0.85	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	23.31	5.62	2.70	2.32
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.42	4.63	1.23	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.56	6.45	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.05	4.70	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.25	7.07	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.51	7.88	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.95	7.73	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	1.00	1.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.44	7.19	0.67	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.28	7.76	1.33	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	31.88	9.86	1.92	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	15.30	3.91	1.30	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	19.79	4.43	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.38	4.27	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.58	1.95	0.49	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	15.53	2.44	2.13	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	19.19	6.06	0.76	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.17	3.34	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.14	6.34	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.80	3.66	0.65	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.45	9.24	0.63	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.26	11.29	0.62	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	5.39	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.61	8.67	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.56	4.78	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.29	4.32	1.73	1.49
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	14.49	7.85	1.01	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.11	7.96	0.46	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.91	2.42	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	74.18	47.16	2.12	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.17	6.79	1.33	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	20.66	8.64	0.63	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	7.86	0.51	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.22	10.55	0.30	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	4.50	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	5.17	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.88	8.37	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	15.15	3.03	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.42	4.70	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	0.88	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	41.65	20.08	3.08	3.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	11.68	1.87	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.82	7.63	0.72	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.06	7.14	1.02	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.12	6.77	1.13	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	34.52	13.56	1.68	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	22.12	7.46	0.92	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.67	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.86	4.40	0.49	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	36.68	17.68	1.77	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	13.75	4.10	0.59	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.86	2.14	1.75	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.49	3.70	1.06	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.93	6.32	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.94	2.87	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.90	7.10	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	38.21	16.15	0.00	3.15
Smooth muscle cells - airway, control, donor1	11966-126D4	16.00	4.32	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	11.18	2.40	2.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	10.45	5.02	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	10.54	1.83	0.00	0.46
Synoviocyte, donor1	11291-117A4	14.98	8.08	0.84	1.01
Synoviocyte, donor2	11368-117I9	11.90	3.35	1.01	1.68
Synoviocyte, donor3	11440-118H9	9.83	2.23	0.22	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	16.79	4.29	1.79	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	9.91	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.59	3.01	1.16	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	35.34	18.78	1.58	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	14.30	6.19	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	22.91	14.89	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	22.88	5.17	1.48	1.97
Urethra, donor2	10319-105A4	30.57	5.40	1.80	0.00
Urothelial Cells, donor1	11520-119H8	3.98	1.33	0.80	0.00
Urothelial Cells, donor2	11600-120H7	7.21	2.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.19	0.92	0.23	0.00
Urothelial cells, donor0	11216-116B1	24.52	7.13	0.67	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	38.26	5.34	2.67	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	35.74	4.29	4.29	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.85	3.42	1.37	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.20	7.23	4.13	8.26
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.89	4.07	5.81	8.72
Whole blood (ribopure), donor090612, donation1	12182-129A4	23.95	3.12	4.16	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	31.20	7.34	9.18	8.26
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.04	2.74	2.74	2.74
Wilms' tumor cell line:G-401	10809-111A8	50.21	28.37	1.11	1.23
Wilms' tumor cell line:HFWT	10597-108E3	82.72	8.80	6.16	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	57.82	23.74	3.63	0.56
achilles tendon, donor2	10292-104G4	33.06	4.13	4.13	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	80.57	67.82	2.80	3.31
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	102.39	109.35	3.95	4.64
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	131.88	82.15	5.46	5.82
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	93.88	79.46	4.35	3.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	90.51	97.25	1.12	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	61.96	39.12	2.33	5.08
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	81.94	35.93	11.43	9.80
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	80.20	65.21	1.76	3.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	64.52	59.21	2.86	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	126.97	90.09	1.55	5.82
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	66.42	96.23	1.84	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	81.91	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	73.43	82.03	2.56	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	132.30	140.07	3.11	4.92
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	66.05	89.43	2.34	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	54.38	24.63	4.65	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	57.99	36.60	4.11	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	41.13	14.12	1.84	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	62.73	55.05	1.28	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	45.49	48.83	1.82	2.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	51.27	59.94	0.72	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	68.38	56.35	2.90	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	95.73	57.70	5.34	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	217.41	53.89	11.15	11.15
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	116.76	103.58	5.27	3.77
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	162.24	75.89	5.67	5.67
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	206.19	41.24	20.62	13.12
adenocarcinoma cell line:IM95m	10796-110I4	54.87	29.44	1.18	0.94
adipose tissue, adult, pool1	10010-101C1	16.29	2.95	1.24	1.24
adipose, donor1	10184-103D4	103.21	13.49	13.49	7.62
adipose, donor2	10185-103D5	23.93	2.43	5.27	2.84
adipose, donor3	10186-103D6	40.30	5.99	6.26	4.63
adipose, donor4	10187-103D7	67.61	18.20	4.33	8.67
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	111.58	13.41	4.58	4.26
adrenal gland, adult, pool1	10081-102A9	32.74	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	65.24	15.61	3.07	4.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	110.41	51.81	1.07	2.14
amniotic membrane cells, donor1	12235-129G3	19.24	5.33	0.93	1.16
amniotic membrane cells, donor2	12236-129G4	26.71	3.72	0.34	2.70
amniotic membrane cells, donor3	12237-129G5	21.21	2.36	0.88	1.18
amygdala - adult, donor10196	10167-103B5	24.90	2.37	0.00	2.37
amygdala, adult, donor10252	10151-102I7	34.47	3.45	1.01	1.62
amygdala, newborn, donor10223	10360-105E9	18.08	1.29	1.29	2.90
anaplastic carcinoma cell line:8305C	10428-106D5	31.96	2.93	6.49	6.37
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	90.23	58.47	1.76	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	97.87	17.37	6.01	6.35
aorta, adult, pool1	10052-101G7	22.16	3.14	2.75	0.98
appendix, adult	10189-103D9	34.15	8.93	4.66	4.27
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	54.34	25.80	2.06	2.75
artery, adult	10190-103E1	14.95	4.08	6.79	4.08
astrocytoma cell line:TM-31	10425-106D2	47.37	18.11	4.06	2.75
b cell line:RPMI1788	10427-106D4	55.61	20.67	3.42	4.01
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.98	4.99	0.55	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	158.37	103.90	8.43	6.25
bile duct carcinoma cell line:TFK-1	10496-107C1	38.33	27.45	1.51	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	44.18	23.49	3.91	1.68
bladder, adult, pool1	10011-101C2	18.58	2.93	2.82	2.17
blood, adult, pool1	10053-101G8	22.15	0.00	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	2.57	2.57	4.28
bone marrow, adult	10192-103E3	35.09	12.82	1.35	1.35
brain, adult, donor1	10084-102B3	8.20	4.10	5.13	1.03
brain, adult, pool1	10012-101C3	15.48	2.34	2.34	1.89
brain, fetal, pool1	10085-102B4	18.70	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	91.84	7.60	10.90	13.54
breast carcinoma cell line:MDA-MB-453	10419-106C5	184.61	45.81	22.59	16.60
breast, adult, donor1	10080-102A8	20.20	2.53	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	57.68	45.23	0.76	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	97.40	34.32	4.02	3.71
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	51.80	24.63	0.92	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	51.81	26.63	2.42	1.69
carcinoid cell line:NCI-H1770	10703-109H1	97.32	24.45	1.88	2.82
carcinoid cell line:NCI-H727	10735-110B6	67.49	23.74	6.34	6.78
carcinoid cell line:SK-PN-DW	10719-109I8	90.95	18.70	0.63	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	66.28	14.91	3.99	2.93
caudate nucleus - adult, donor10196	10177-103C6	29.93	6.91	5.76	10.36
caudate nucleus, adult, donor10252	10164-103B2	29.11	1.67	3.01	3.51
caudate nucleus, adult, donor10258	10379-105H1	21.40	1.53	4.58	6.11
caudate nucleus, newborn, donor10223	10354-105E3	20.51	2.93	4.76	4.39
cerebellum - adult, donor10196	10173-103C2	64.09	0.00	2.91	5.83
cerebellum, adult, donor10252	10166-103B4	44.84	2.99	2.56	1.49
cerebellum, adult, pool1	10083-102B2	17.94	2.07	1.03	1.03
cerebellum, newborn, donor10223	10357-105E6	25.74	4.98	0.83	4.15
cerebral meninges, adult	10188-103D8	24.21	2.52	1.01	2.52
cerebrospinal fluid, donor2	10294-104G6	21.20	6.58	2.19	2.92
cervical cancer cell line:D98-AH2	10552-107I3	57.08	27.32	6.04	5.03
cervical cancer cell line:ME-180	10553-107I4	59.33	21.21	5.63	5.30
cervix, adult, pool1	10013-101C4	23.20	4.20	4.20	4.41
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	82.49	20.06	7.52	6.55
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	78.92	28.09	7.58	5.59
choriocarcinoma cell line:SCH	10785-110H2	38.07	16.63	1.23	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	86.81	20.87	7.12	2.61
chorionic membrane cells, donor1	12238-129G6	18.80	1.71	1.71	2.28
chorionic membrane cells, donor2	12239-129G7	22.57	6.56	0.60	0.89
chorionic membrane cells, donor3	12240-129G8	24.73	4.95	1.65	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	55.54	38.37	7.07	9.09
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	71.46	56.09	2.31	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	79.41	70.11	3.38	3.17
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	111.19	76.53	2.57	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	131.10	85.62	6.05	2.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	115.65	91.01	6.31	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	112.48	131.03	4.12	2.94
chronic myelogenous leukemia cell line:KU812	10409-106B4	99.82	111.81	6.26	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	70.17	16.23	0.91	1.14
clear cell carcinoma cell line:TEN	10636-108I6	41.12	23.08	1.04	1.56
colon carcinoma cell line:CACO-2	10513-107D9	58.76	44.66	1.10	1.10
colon carcinoma cell line:COLO-320	10420-106C6	207.52	94.64	4.18	3.42
colon, adult, donor1	10082-102B1	23.80	3.57	1.19	2.38
colon, adult, pool1	10014-101C5	20.56	6.58	2.70	2.47
colon, fetal, donor1	10070-101I7	14.21	1.24	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	110.00	18.33	32.08	32.08
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	50.07
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	71.39	53.54	2.97	6.80
cord blood derived cell line:COBL-a 24h infection	10453-106G3	64.90	62.64	2.26	2.41
cord blood derived cell line:COBL-a untreated	10449-106F8	76.29	68.81	1.97	2.96
corpus callosum, adult, pool1	10042-101F6	27.09	3.87	2.65	3.65
cruciate ligament, donor2	10295-104G7	42.95	4.05	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	22.47	3.21	2.41	3.21
diencephalon, adult	10193-103E4	14.64	2.16	2.40	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	132.94	69.80	6.20	5.97
ductal cell carcinoma cell line:KLM-1	10438-106E6	88.22	43.59	10.00	13.33
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	93.64	48.63	4.57	0.24
ductus deferens, adult	10196-103E7	29.40	4.98	1.99	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	11.52	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.99	7.36	4.41	0.74
dura mater, adult, donor1	10041-101F5	19.41	3.55	5.70	8.01
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	89.72	55.30	13.32	9.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	79.24	59.90	2.29	2.01
embryonic pancreas cell line:1B2C6	10604-108F1	73.99	8.63	2.47	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	42.08	8.17	0.91	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	71.01	9.88	3.09	0.62
embryonic pancreas cell line:2C6	10603-108E9	73.55	11.82	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	75.75	25.14	4.36	3.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	52.01	12.14	4.17	3.44
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	29.11	8.68	0.80	0.48
epidermoid carcinoma cell line:A431	10426-106D3	72.59	34.46	3.45	2.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	79.30	38.49	6.60	4.40
epididymis, adult	10197-103E8	16.74	1.88	2.72	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	36.55	5.85	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	55.45	24.77	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	101.56	83.35	2.49	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	96.85	71.26	2.66	4.53
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	105.76	74.28	2.13	2.02
esophagus, adult, pool1	10015-101C6	23.25	6.80	3.29	1.70
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	70.76	24.67	3.01	2.88
eye - muscle inferior rectus, donor1	10272-104E2	43.46	4.83	0.00	9.66
eye - muscle lateral, donor2	10298-104H1	39.98	10.52	6.31	6.31
eye - muscle medial, donor2	10299-104H2	26.79	0.00	8.93	1.49
eye - muscle superior, donor2	10297-104G9	38.98	10.32	5.73	2.29
eye - vitreous humor, donor1	10268-104D7	32.06	14.57	1.46	0.00
eye, fetal, donor1	10054-101G9	20.59	3.31	2.54	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	49.62	20.77	1.41	1.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	49.86	30.63	1.19	0.47
frontal lobe, adult, pool1	10040-101F4	21.02	2.06	1.88	2.25
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	114.09	34.23	5.10	4.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	32.73	8.32	2.47	1.74
gall bladder, adult	10198-103E9	21.49	3.38	1.21	2.41
gamma delta positive T cells, donor1	11937-126A2	24.70	2.15	6.98	13.42
gamma delta positive T cells, donor2	11938-126A3	28.01	2.61	5.23	6.35
gastric adenocarcinoma cell line:MKN1	10614-108G2	54.28	24.50	2.53	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	58.80	27.47	4.84	3.09
gastric cancer cell line:AZ521	10549-107H9	70.83	37.22	1.15	0.66
gastric cancer cell line:GSS	10560-108A2	165.66	38.44	2.75	5.49
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.49	17.59	6.17	3.66
giant cell carcinoma cell line:LU65	10487-107B1	139.29	49.45	6.31	2.98
giant cell carcinoma cell line:Lu99B	10433-106E1	38.63	7.70	3.22	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	40.90	13.72	3.49	5.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	35.99	12.98	2.53	2.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	47.47	14.75	3.79	2.81
glioblastoma cell line:T98G	10485-107A8	44.37	14.68	2.76	1.66
glioma cell line:GI-1	10413-106B8	28.70	13.77	2.05	1.46
globus pallidus - adult, donor10196	10175-103C4	29.16	2.92	2.19	4.37
globus pallidus, adult, donor10252	10161-103A8	40.76	6.10	2.93	1.95
globus pallidus, adult, donor10258	10367-105F7	23.28	4.11	6.85	5.48
globus pallidus, newborn, donor10223	10364-105F4	18.12	2.66	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	85.65	17.13	22.02	24.47
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	15.68	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	24.32	5.44	1.28	0.96
hIPS +CCl2, biol_rep1	14383-156B9	83.56	29.84	11.02	4.13
hIPS +CCl2, biol_rep2	14384-156C1	80.48	31.09	5.03	4.12
hIPS +CCl2, biol_rep3	14385-156C2	91.46	26.41	8.37	12.24
hIPS, biol_rep1	14380-156B6	87.67	17.25	8.62	5.75
hIPS, biol_rep2	14381-156B7	78.19	29.49	10.29	3.43
hIPS, biol_rep3	14382-156B8	30.90	5.52	3.31	6.62
hairy cell leukemia cell line:Mo	10712-109I1	49.14	14.65	1.44	1.15
heart - mitral valve, adult	10205-103F7	26.01	3.59	5.38	3.89
heart - pulmonic valve, adult	10206-103F8	22.49	3.14	4.71	6.28
heart - tricuspid valve, adult	10207-103F9	51.62	11.66	0.83	6.66
heart, adult, diseased post-infarction, donor1	10050-101G5	22.65	4.90	2.24	1.43
heart, adult, diseased, donor1	10051-101G6	15.76	2.98	3.41	2.55
heart, adult, pool1	10016-101C7	17.02	2.30	7.13	2.76
heart, fetal, pool1	10046-101G1	25.05	3.59	8.83	7.80
hepatic mesenchymal tumor cell line:LI90	10778-110G4	23.14	1.54	0.93	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	197.40	26.16	15.46	13.08
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	82.76	62.87	1.22	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	76.10	69.18	1.46	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	72.25	68.41	2.22	1.21
hepatoma cell line:Li-7	10484-107A7	60.84	34.03	2.11	1.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	83.62	61.10	3.62	2.41
hippocampus - adult, donor10196	10169-103B7	28.39	2.84	4.73	1.89
hippocampus, adult, donor10252	10153-102I9	31.64	3.47	2.25	3.88
hippocampus, adult, donor10258	10374-105G5	26.89	2.99	5.98	2.99
hippocampus, newborn, donor10223	10363-105F3	15.86	2.11	1.41	3.17
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	156.25	42.72	13.43	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	62.83	18.46	5.69	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	73.12	16.00	8.12	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	25.94	3.38	3.38	7.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	35.63	5.42	2.58	7.23
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	28.47	3.42	7.97	10.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	43.21	3.80	10.80	8.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	35.76	3.45	7.76	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.62	4.59	7.92	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	37.89	9.95	4.74	7.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.82	9.64	5.79	5.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	35.69	9.43	3.37	8.75
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	57.74	17.84	4.85	4.23
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	74.19	19.16	7.86	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	99.49	25.31	8.73	8.73
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	33.03	3.63	3.82	5.35
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.53	1.74	5.23	5.23
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	54.97	4.00	8.00	7.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	26.75	1.51	4.33	5.65
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	31.38	1.82	4.55	6.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.19	3.13	7.83	4.70
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	28.74	4.57	3.59	5.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	23.22	3.48	5.23	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	40.95	4.18	8.37	6.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	66.88	22.35	6.65	2.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	63.90	16.55	3.71	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	103.30	35.93	13.88	6.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.21	5.28	2.46	4.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	30.09	4.12	7.29	3.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	30.87	6.05	3.63	6.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	31.54	4.14	4.14	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	25.24	0.66	7.97	9.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	29.76	3.33	7.70	8.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.05	6.90	5.37	4.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	32.56	3.03	5.30	8.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	34.28	8.40	7.06	8.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	62.31	27.53	3.86	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	74.43	24.51	7.13	7.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	87.81	27.81	5.85	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	36.06	2.44	5.81	3.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	178.93	45.55	42.29	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	47.32	4.30	7.61	8.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.18	1.09	7.11	7.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	27.87	1.81	7.24	12.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	30.60	1.07	5.69	7.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	32.22	2.39	5.97	7.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	39.68	7.85	9.75	4.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.40	5.66	4.85	5.66
immature langerhans cells, donor1	11904-125F5	28.09	5.81	3.87	5.81
immature langerhans cells, donor2	11905-125F6	15.84	3.17	0.79	3.96
insula, adult, pool1	10039-101F3	21.29	2.65	2.65	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	35.44	19.18	0.65	0.65
kidney, adult, pool1	10017-101C8	19.93	4.71	1.50	1.60
kidney, fetal, pool1	10045-101F9	26.53	3.89	3.82	3.47
large cell lung carcinoma cell line:IA-LM	10509-107D5	100.98	42.04	8.52	7.39
large cell lung carcinoma cell line:NCI-H460	10839-111E2	42.72	22.67	3.32	2.49
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	72.30	16.88	6.61	5.32
left atrium, adult, donor1	10079-102A7	13.62	4.36	2.18	0.54
left ventricle, adult, donor1	10078-102A6	16.18	1.01	2.53	2.02
leiomyoblastoma cell line:G-402	10721-110A1	80.99	24.35	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	11.14	1.80	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	13.04	4.35	0.00	0.00
leiomyoma cell line:15425	10571-108B4	15.30	6.31	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	54.37	5.23	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	122.66	118.06	4.60	1.42
liposarcoma cell line:KMLS-1	10782-110G8	28.59	10.93	0.78	1.09
liposarcoma cell line:SW 872	10726-110A6	62.38	20.83	3.90	3.90
liver, adult, pool1	10018-101C9	21.55	8.43	0.81	0.16
liver, fetal, pool1	10086-102B5	17.87	4.70	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	26.69	3.35	4.23	2.48
locus coeruleus, adult, donor10252	10165-103B3	30.64	3.88	2.03	2.77
locus coeruleus, adult, donor10258	10375-105G6	14.11	1.13	1.41	1.13
locus coeruleus, newborn, donor10223	10362-105F2	26.08	7.15	3.36	1.26
lung adenocarcinoma cell line:A549	10499-107C4	50.65	16.88	3.74	2.63
lung adenocarcinoma cell line:PC-14	10408-106B3	51.71	5.52	4.14	4.14
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	66.44	22.15	2.77	3.16
lung, adult, pool1	10019-101D1	14.88	1.89	1.77	2.13
lung, fetal, donor1	10068-101I5	32.54	7.71	5.14	7.42
lung, right lower lobe, adult, donor1	10075-102A3	17.41	2.75	1.83	2.29
lymph node, adult, donor1	10077-102A5	23.67	3.79	2.84	5.68
lymphangiectasia cell line:DS-1	10727-110A7	60.93	14.03	3.95	3.07
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	138.40	81.95	13.28	14.04
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	67.96	58.62	9.34	0.85
mature adipocyte, donor1	12231-129F8	15.54	0.89	1.78	3.11
mature adipocyte, donor2	12232-129F9	16.39	1.66	1.45	1.45
mature adipocyte, donor3	12233-129G1	13.51	2.13	1.42	1.90
mature adipocyte, donor4	12234-129G2	15.79	2.11	1.84	2.11
maxillary sinus tumor cell line:HSQ-89	10414-106B9	160.11	45.03	16.44	10.25
medial frontal gyrus - adult, donor10196	10170-103B8	32.71	4.51	6.77	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	34.02	4.23	2.39	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	26.37	4.13	3.49	2.22
medial frontal gyrus, newborn, donor10223	10352-105E1	28.15	5.97	3.84	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	26.33	3.54	3.54	3.21
medial temporal gyrus, adult, donor10252	10156-103A3	34.80	3.40	2.12	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	42.38	1.93	5.78	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	28.71	14.35	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	17.59	3.23	1.79	2.51
medulla oblongata - adult, donor10196	10174-103C3	33.75	4.54	3.89	2.60
medulla oblongata, adult, donor10252	10155-103A2	31.12	4.33	2.63	2.01
medulla oblongata, adult, pool1	10038-101F2	21.88	2.53	4.33	3.59
medulla oblongata, newborn, donor10223	10361-105F1	17.71	2.08	3.82	3.12
medulloblastoma cell line:D283 Med	10838-111E1	128.64	65.76	3.32	0.89
medulloblastoma cell line:ONS-76	10759-110E3	75.81	26.17	1.83	2.81
melanoma cell line:COLO 679	10514-107E1	38.09	18.11	2.01	1.29
melanoma cell line:G-361	10465-106H6	49.13	27.69	2.44	0.81
meningioma cell line:HKBMM	10691-109F7	53.19	9.59	1.45	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	79.30	44.06	3.52	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	86.84	37.59	2.33	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	32.37	21.17	0.31	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.36	9.09	0.00	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.22	11.18	1.24	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.06	4.07	0.70	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.79	4.62	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	2.08	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.22	6.35	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	19.09	6.33	0.58	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.95	9.68	0.80	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.39	12.83	1.08	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	26.75	10.53	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	6.59	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.57	5.67	0.55	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.64	7.68	0.35	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	16.13	2.45	0.61	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.46	2.52	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.66	2.17	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.21	3.19	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	40.28	21.82	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.93	5.38	0.15	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.06	4.99	0.18	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.30	1.84	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.16	2.86	0.57	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.05	12.63	0.42	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.53	3.65	0.00	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.11	3.33	1.53	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.18	5.76	0.00	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.10	3.39	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.53	4.94	1.18	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.23	2.71	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.86	4.72	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.44	5.56	1.39	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.59	5.48	1.44	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.73	4.69	1.12	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.18	6.01	0.96	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.00	9.53	0.73	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	16.11	6.04	1.01	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.51	4.50	1.23	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.89	4.30	0.86	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.94	4.22	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	5.82	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.93	3.20	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	4.91	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.38	3.50	1.17	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	2.10	4.20	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	4.97	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	2.37	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	1.22	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.83	6.33	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.83	3.45	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	10.33	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.63	2.44	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	6.36	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	5.31	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.78	3.43	0.31	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	5.35	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	7.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	20.65	6.88	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	15.83	5.94	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	5.61	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	19.72	5.72	3.18	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	15.31	5.24	1.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	24.07	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.96	3.64	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.71	3.17	0.99	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	14.93	4.22	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	5.09	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	13.15	2.32	3.87	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	105.84	10.39	2.83	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	38.46	14.13	0.23	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	38.46	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.80	17.88	0.51	1.03
mesothelioma cell line:Mero-25	10850-111F4	79.89	36.31	4.09	2.50
mesothelioma cell line:Mero-41	10851-111F5	64.54	33.00	2.69	0.73
mesothelioma cell line:Mero-48a	10852-111F6	38.97	14.39	1.33	1.99
mesothelioma cell line:Mero-82	10853-111F7	59.13	43.10	1.84	1.58
mesothelioma cell line:Mero-83	10854-111F8	40.00	19.58	0.85	0.68
mesothelioma cell line:Mero-84	10855-111F9	35.64	14.66	0.25	2.02
mesothelioma cell line:Mero-95	10856-111G1	25.47	13.46	1.04	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	47.71	30.98	1.33	0.99
mesothelioma cell line:NCI-H226	10846-111E9	47.78	40.72	1.09	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	38.09	14.52	0.68	1.54
mesothelioma cell line:NCI-H28	10845-111E8	65.91	25.96	2.54	2.29
mesothelioma cell line:No36	10857-111G2	70.79	44.04	2.28	1.96
mesothelioma cell line:ONE58	10858-111G3	51.75	42.27	0.81	1.90
migratory langerhans cells, donor1	11901-125F2	17.66	2.88	2.30	1.15
migratory langerhans cells, donor2	11902-125F3	18.81	2.69	1.10	1.47
migratory langerhans cells, donor3	11903-125F4	20.64	3.23	2.69	2.87
mixed mullerian tumor cell line:HTMMT	10689-109F5	46.03	6.53	2.61	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.91	8.05	1.06	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	151.81	51.60	5.07	3.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	29.88	10.66	1.52	4.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	116.79	95.72	4.80	5.36
myeloma cell line:PCM6	10474-106I6	33.21	20.36	2.37	3.36
myxofibrosarcoma cell line:MFH-ino	10600-108E6	81.67	14.20	3.04	4.06
myxofibrosarcoma cell line:NMFH-1	10684-109E9	38.44	17.46	1.37	1.57
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.21	10.36	0.45	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.09	8.82	1.18	0.66
nasal epithelial cells, donor2	12227-129F4	32.57	16.56	1.10	1.10
neuroblastoma cell line:CHP-134	10508-107D4	120.55	59.59	7.13	8.28
neuroblastoma cell line:NB-1	10539-107G8	76.71	24.51	4.30	5.80
neuroblastoma cell line:NBsusSR	10607-108F4	83.93	33.11	4.01	2.32
neuroblastoma cell line:NH-12	10555-107I6	113.49	44.72	7.83	7.08
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	58.59	11.86	2.85	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	55.75	13.30	2.53	1.90
neuroectodermal tumor cell line:TASK1	10774-110F9	101.64	44.68	2.21	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	121.43	19.07	4.45	5.72
neurofibroma cell line:Hs 53.T	10729-110A9	27.68	10.65	1.06	1.60
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	14.87
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	142.57	69.85	7.10	4.23
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	53.63	26.42	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	18.92	3.21	1.28	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	14.45	4.20	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	22.87	2.34	2.62	3.84
occipital cortex - adult, donor10196	10172-103C1	37.09	8.24	6.18	2.06
occipital cortex, adult, donor10252	10163-103B1	46.16	5.64	3.76	1.88
occipital cortex, newborn, donor10223	10355-105E4	16.74	3.28	3.28	1.82
occipital lobe, adult, donor1	10076-102A4	18.11	1.84	0.52	1.84
occipital lobe, fetal, donor1	10073-102A1	28.75	2.15	2.57	3.43
occipital pole, adult, pool1	10036-101E9	16.79	1.42	2.13	3.47
olfactory region, adult	10195-103E6	23.31	2.10	1.72	3.44
optic nerve, donor1	10277-104E7	42.02	2.00	8.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	69.94	43.40	2.96	2.28
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	80.51	24.73	1.65	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	53.00	33.86	2.71	5.42
oral squamous cell carcinoma cell line:SAS	10544-107H4	50.59	28.30	1.62	1.39
osteoclastoma cell line:Hs 706.T	10704-109H2	24.99	2.65	1.47	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	111.19	19.62	37.37	29.90
osteosarcoma cell line:HS-Os-1	10558-107I9	42.20	27.78	1.48	2.12
ovary, adult, pool1	10020-101D2	24.11	3.14	5.42	5.68
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	75.34	18.52	3.30	1.83
pancreas, adult, donor1	10049-101G4	47.97	8.47	1.88	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	103.15	29.91	12.86	7.55
papillary adenocarcinoma cell line:8505C	10437-106E5	65.25	27.09	4.77	3.41
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	51.50	19.21	3.15	2.32
paracentral gyrus, adult, pool1	10035-101E8	18.40	1.65	1.83	3.11
parietal cortex, adult, donor10258	10373-105G4	12.48	1.47	3.67	5.14
parietal lobe - adult, donor10196	10171-103B9	34.80	6.58	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	37.34	2.57	0.29	1.71
parietal lobe, adult, pool1	10034-101E7	21.41	4.05	1.50	2.29
parietal lobe, fetal, donor1	10072-101I9	35.88	3.88	2.91	6.79
parietal lobe, newborn, donor10223	10356-105E5	24.67	2.62	2.24	1.12
parotid gland, adult	10199-103F1	25.28	2.47	4.93	4.32
penis, adult	10200-103F2	20.95	4.30	5.91	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	35.14	3.35	1.49	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	52.74	21.71	2.62	2.77
pineal gland - adult, donor10196	10179-103C8	49.67	5.16	6.45	7.10
pineal gland, adult, donor10252	10160-103A7	85.28	8.29	6.51	7.70
pineal gland, adult, donor10258	10377-105G8	48.91	7.52	7.52	13.17
pituitary gland - adult, donor10196	10180-103C9	48.57	3.04	5.06	5.06
pituitary gland, adult, donor10252	10162-103A9	69.32	6.78	7.82	4.17
pituitary gland, adult, donor10258	10378-105G9	37.45	1.70	5.11	5.96
placenta, adult, pool1	10021-101D3	22.25	4.41	2.26	2.69
plasma cell leukemia cell line:ARH-77	10840-111E3	54.56	22.12	3.84	3.31
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.37	3.74	2.33	1.09
pons, adult, pool1	10033-101E6	20.31	4.05	3.70	2.84
postcentral gyrus, adult, pool1	10032-101E5	20.14	2.18	2.62	4.53
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	6.27	18.82	23.01
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	22.03	5.51	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	54.04	26.66	1.46	0.87
prostate cancer cell line:PC-3	10439-106E7	118.88	41.75	2.72	1.45
prostate, adult, pool1	10022-101D4	23.04	1.81	3.45	3.08
putamen, adult, donor10196	10176-103C5	28.09	1.65	2.60	3.07
putamen, adult, donor10252	10152-102I8	41.18	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	54.64	6.56	10.93	6.56
putamen, adult, donor10258, tech_rep2	10372-105G3	17.88	1.21	5.56	4.83
putamen, newborn, donor10223	10365-105F5	14.99	6.00	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	124.52	36.95	5.24	4.36
rectum, fetal, donor1	10067-101I4	41.73	2.78	2.78	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.68	11.45	1.06	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	77.04	5.38	2.49	0.83
retina, adult, pool1	10030-101E3	18.59	2.39	5.07	5.37
retinoblastoma cell line:Y79	10475-106I7	179.52	96.39	5.46	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	62.33	15.37	1.72	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	237.61	52.02	5.06	4.50
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	2.27	4.55	3.79
salivary acinar cells, donor1	11771-123I7	34.31	13.27	1.13	0.16
salivary acinar cells, donor2	11772-123I8	21.20	10.60	1.51	2.34
salivary acinar cells, donor3	11773-123I9	19.20	3.31	0.66	0.66
salivary gland, adult, pool1	10093-102C3	33.17	4.58	5.15	4.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	51.85	25.80	2.28	1.85
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	58.42	25.63	1.29	1.41
seminal vesicle, adult	10201-103F3	23.81	3.17	5.29	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	47.37	18.22	3.40	3.40
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	28.94	4.03	2.77	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	46.16	13.05	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	36.67	14.51	1.34	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	69.08	30.28	3.43	2.21
signet ring carcinoma cell line:NUGC-4	10483-107A6	87.35	93.29	1.42	1.81
skeletal muscle - soleus muscle, donor1	10282-104F3	46.11	2.13	12.06	9.93
skeletal muscle, adult, pool1	10023-101D5	31.30	3.24	5.16	4.32
skeletal muscle, fetal, donor1	10066-101I3	22.11	2.01	2.01	0.00
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	41.03	7.57	2.52	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	52.36	19.34	1.33	3.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	98.03	31.52	5.99	6.30
small cell lung carcinoma cell line:DMS 144	10841-111E4	53.78	7.90	2.89	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	85.38	64.45	2.97	2.97
small cell lung carcinoma cell line:NCI-H82	10842-111E5	192.54	28.79	9.49	5.15
small cell lung carcinoma cell line:WA-hT	10562-108A4	73.87	36.61	7.19	6.32
small intestine, adult, pool1	10024-101D6	23.29	8.72	2.15	1.91
small intestine, fetal, donor1	10064-101I1	28.99	6.63	4.18	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	64.11	22.05	3.08	1.03
smooth muscle, adult, pool1	10048-101G3	20.93	1.81	3.10	2.33
somatostatinoma cell line:QGP-1	10781-110G7	105.06	21.71	4.56	3.22
spinal cord - adult, donor10196	10181-103D1	43.36	4.13	3.67	1.61
spinal cord, adult, donor10252	10159-103A6	31.15	4.34	1.97	1.97
spinal cord, adult, donor10258	10369-105F9	29.06	3.46	6.23	4.84
spinal cord, fetal, donor1	10056-101H2	26.83	3.66	2.44	2.44
spinal cord, newborn, donor10223	10359-105E8	33.06	4.59	2.30	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.38	7.92	2.09	0.75
spleen, adult, pool1	10025-101D7	24.89	11.89	3.63	3.52
spleen, fetal, pool1	10044-101F8	32.97	9.77	3.02	3.50
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	52.69	32.09	3.42	3.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	49.37	20.51	1.52	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.66	8.74	2.45	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	98.12	25.41	3.91	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	139.24	53.92	15.42	12.72
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	108.44	50.41	6.35	3.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	79.11	24.54	1.69	2.54
stomach, fetal, donor1	10062-101H8	67.28	4.27	9.61	4.27
submaxillary gland, adult	10202-103F4	28.48	4.56	6.27	7.41
substantia nigra - adult, donor10196	10178-103C7	217.10	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	29.29	3.12	1.25	1.25
substantia nigra, adult, donor10258	10371-105G2	25.86	3.10	9.83	7.76
substantia nigra, newborn, donor10223	10358-105E7	26.14	5.65	1.41	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	117.84	55.71	2.29	1.15
temporal lobe, adult, pool1	10031-101E4	19.75	1.78	2.54	3.05
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.76	7.12	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	19.78	4.40	4.40	0.88
tenocyte, donor1	11763-123H8	17.46	5.93	0.35	0.35
tenocyte, donor2	11765-123I1	7.63	3.82	0.38	0.38
tenocyte, donor3	11768-123I4	20.02	8.90	1.48	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	179.48	66.96	8.50	6.12
teratocarcinoma cell line:NCR-G1	10798-110I6	92.49	31.75	2.00	2.77
teratocarcinoma cell line:PA-1	10807-111A6	77.18	17.82	6.66	4.80
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	135.20	49.00	4.44	3.05
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	180.77	32.14	20.04	13.99
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	129.78	33.59	6.00	5.23
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	102.60	25.08	18.89	14.98
testis, adult, pool1	10026-101D8	25.77	10.20	2.68	2.04
testis, adult, pool2	10096-102C6	55.03	27.52	5.86	7.67
thalamus - adult, donor10196	10168-103B6	40.85	5.52	2.21	2.21
thalamus, adult, donor10252	10154-103A1	31.41	3.44	3.28	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	3.08	6.16	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.07	1.32	1.48	1.15
thalamus, newborn, donor10223	10366-105F6	18.99	6.90	1.15	0.00
throat, adult	10209-103G2	21.47	5.74	3.75	5.24
throat, fetal, donor1	10061-101H7	33.82	2.44	6.09	5.48
thymic carcinoma cell line:Ty-82	10803-111A2	74.52	50.28	0.79	1.39
thymus, adult, pool1	10027-101D9	37.28	9.35	5.87	6.96
thymus, fetal, pool1	10043-101F7	34.81	7.69	5.20	4.99
thyroid carcinoma cell line:KHM-5M	10776-110G2	55.58	24.20	2.53	3.99
thyroid carcinoma cell line:TCO-1	10783-110G9	76.13	20.81	2.51	3.49
thyroid, adult, pool1	10028-101E1	37.79	3.64	5.60	6.53
thyroid, fetal, donor1	10060-101H6	40.60	3.16	5.27	4.75
tongue epidermis (fungiform papillae), donor1	10288-104F9	76.99	6.16	9.24	6.16
tongue, adult	10203-103F5	28.61	11.16	2.56	2.33
tongue, fetal, donor1	10059-101H5	29.95	7.88	3.94	2.36
tonsil, adult, pool1	10047-101G2	36.06	11.22	7.31	5.31
trachea, adult, pool1	10029-101E2	24.62	8.59	3.35	1.80
trachea, fetal, donor1	10058-101H4	37.70	7.69	2.69	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.59	13.82	1.06	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	75.58	40.93	3.95	3.65
transitional-cell carcinoma cell line:JMSU1	10492-107B6	149.95	45.13	3.92	3.13
tridermal teratoma cell line:HGRT	10694-109G1	38.05	5.71	3.81	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	49.77	17.52	1.35	2.45
umbilical cord, fetal, donor1	10057-101H3	14.61	4.17	0.00	6.26
uterus, adult, pool1	10100-102D1	30.37	4.44	4.78	5.46
uterus, fetal, donor1	10055-101H1	37.88	4.61	3.07	2.56
vagina, adult	10204-103F6	22.62	0.65	1.29	2.58
vein, adult	10191-103E2	20.17	3.95	5.92	4.38
xeroderma pigentosum b cell line:XPL 17	10563-108A5	30.44	8.81	2.14	1.60